SCHEMBL3363194

SCHEMBL3363194

CO[Si](CCCCCCCCCCC[Si](Cl)(Cl)Cl)(OC)OC

nearest known ligand 0.42

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3360993 0.92 LMNA (0.39) LMNA
SCHEMBL27601257 0.91 LMNA (0.55) LMNA
SCHEMBL399581 0.86 LMNA (0.50) LMNA
SCHEMBL20478196 0.86 LMNA (0.50) LMNA
SCHEMBL314440 0.86 LMNA (0.50) LMNA
SCHEMBL3792627 0.86 LMNA (0.50) LMNA
SCHEMBL3741069 0.86 LMNA (0.50) LMNA
SCHEMBL20478198 0.86 LMNA (0.50) LMNA
SCHEMBL6009511 0.86 LMNA (0.50) LMNA
SCHEMBL396922 0.86 LMNA (0.50) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121710-A1 ASYMMETRIC BIS-SILANES AND METHODS FOR MAKING AND THEIR USE CORNING INCORPORATED (US) 2009-11-25 EP claimed
WO-2008106132-A9 ASYMMETRIC BIS-SILANES AND METHODS FOR MAKING AND THEIR USE CORNING INC (US) 2009-06-18 WO claimed
WO-2008106132-A1 ASYMMETRIC BIS-SILANES AND METHODS FOR MAKING AND THEIR USE CORNING INCORPORATED (US) 2008-09-04 WO claimed
US-20080207937-A1 Asymmetric bis-silanes and methods for making and their use CORNING INCORPORATED 2008-08-28 US claimed
US-7671227-B2 Asymmetric bis-silanes and methods for making and their use CORNING INCORPORATED (US) 2010-03-02 US disclosed
US-7671227-B2 Asymmetric bis-silanes and methods for making and their use CORNING INCORPORATED (US) 2010-03-02 US disclosed
EP-2121710-A1 ASYMMETRIC BIS-SILANES AND METHODS FOR MAKING AND THEIR USE CORNING INCORPORATED (US) 2009-11-25 EP disclosed
WO-2008106132-A9 ASYMMETRIC BIS-SILANES AND METHODS FOR MAKING AND THEIR USE CORNING INC (US) 2009-06-18 WO disclosed
WO-2008106132-A1 ASYMMETRIC BIS-SILANES AND METHODS FOR MAKING AND THEIR USE CORNING INCORPORATED (US) 2008-09-04 WO disclosed
US-20080207937-A1 Asymmetric bis-silanes and methods for making and their use CORNING INCORPORATED 2008-08-28 US disclosed
US-20080207937-A1 Asymmetric bis-silanes and methods for making and their use CORNING INCORPORATED 2008-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207937-A1 Asymmetric bis-silanes and methods for making and their use SIN3A, SPIN3, SUDS3 LMNA 1132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.